Healthcare
Archimed preps Citieffe for sale, Potomac advising
Specialised healthcare investor bought the orthopedic trauma devices manufacturer in 2014
Eterus Capital lines up dealflow with EUR 10m left to deploy from EUR 40m fund
Slovak PE firm is “seriously looking at“ more than 10 potential investments
HSBC raises USD 580m-plus for second UK direct lending vintage
Strategy makes senior secured loans to mid-market private equity backed companies
BlackRock buys growth and venture debt provider Kreos
Global asset manager plans to broaden Global Credit business with fresh acquisition
GP Profile: Limerston Capital anticipates higher volume but more complex M&A as market steadies
UK-based GP is seeing dealflow driven by carve-outs and buy-and-build in a market where organic multiple arbitrage is no longer a given
Archimed closes MED II on EUR 3.5bn
Healthcare-focused GP took 17 months to raise its second mid-cap fund, which has already deployed almost EUR 1bn
Eurazeo-backed DORC catches the eye of dealmakers with H2 process anticipated
Eurazeo acquired the Dutch ophthalmic surgical equipment producer for EUR 430m in 2019
EQT mandates Bank of America for Schuelke sale
GP bought the Germany-based infection prevention firm from France’s Air Liquide in 2020 via EQT VIII
Bewater Funds nears EUR 7m close for second fund, aims to back 20 companies in next four years
Bewater II FCRE takes minority stakes (5%-25%) with tickets of EUR 500,000-EUR 2m, and it has already made three investments.
Mimir Group ramps up global origination effort with London office and focus on life science carve-outs
Stockholm-based investor is considering divestments, although challenging market remains a barrier
Gyrus Capital acquires LRE Medical from KPS-backed AIS Global
Carve-out of German diagnostic equipment manufacturer comes over two years after first sale attempt
The Bolt-Ons Digest - 26 May 2023
Unquote’s selection of the latest add-ons with H&F's TeamSystem, Nordic Capital's Regnology, 3'i's Dutch Bakery and more
Inflexion kicks off Rosemont Pharmaceuticals sale
Liquid pharmaceuticals manufacturer has drawn strategic and PE interest ahead of non-binding offers
GP Profile: Investindustrial eyes near-shoring opportunities as third growth fund closes
GP closed its latest fund within a 12-month period on the road with strong support from European LPs
BC-backed VetPartners sees initial bids fall short of price expectations
Ongoing buyer and seller valuation expectation gap has hit the sale of the vet clinic chain, sources said
Wellspect auction in final stretch with Blackstone, EQT and KKR to battle it out
Owner Dentsply launched a process to sell the Swedish bowel and bladder control products specialist in February
Palatine launches growth credit strategy for UK’s underserved regions
New fund will aim to support VC-backed companies’ growth while extending their cash runway, Will Chappel told Unquote
Pantheon bullish on consolidation opportunities with fresh USD 2.4bn co-investment vehicle
Taking a cautious approach to valuation expectations, the sponsor is deploying its latest fund across small-, mid-cap and growth opportunities
VFF has around EUR 20m to deploy, considers fund volume and investment period increase
Slovak state-backed VC fund expects to invest in 25-30 companies with EUR 500,000 to EUR 4.8m to deploy per round
Heran Partners nears full deployment of debut fund, mulls next fundraise
Health tech-focused VC is seeking three further software and hardware deals from EUR 75m debut vehicle
GP Profile: Ardian Expansion doubles down on generalist approach, eyes EUR 3bn Q2 fundraise launch
With its current EUR 1.5bn fifth fund almost at full deployment, Ardian’s Expansion strategy expects to benefit from LP appetite for its strategy ahead of EUR 3bn fundraise
InvestIndustrial closes third lower mid-market fund on EUR 1.1bn
Strategy will target businesses in Italy, Spain, Portugal and Switzerland with internationalisation potential
Women in VC: MMV’s Brunet on tech opportunities and navigating volatile markets
Alix Brunet speaks to Unquote about the VC firm’s deal pipeline and how it is engaging with portfolio companies and new founders
EQT weighs options for infection prevention firm Schuelke
Sponsor assesses quick flip for German company, acquired via EQT VIII in 2020